Export 6 results:
[ Author(Desc)] Title Type Year
Filters: Author is Bernstein, David I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D. I. Bernstein, Atmar, R. L., G Lyon, M., Treanor, J. J., Chen, W. H., Jiang, X., Vinjé, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults., J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M. El, Spearman, P., Rouphael, N., Rudge, T. L., Hill, H., and Goll, J. B., Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults., Vaccine, vol. 32, no. 47, pp. 6284-93, 2014.
D. I. Bernstein, Bellamy, A. R., Hook, E. W., Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., and Belshe, R. B., Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women., Clin Infect Dis, vol. 56, no. 3, pp. 344-51, 2013.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., Safety and immunogenicity of a candidate parvovirus B19 vaccine., Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K. B., Graham, I. L., Noah, D. L., He, F., and Hill, H., Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults., J Infect Dis, vol. 197, no. 5, pp. 667-75, 2008.
D. I. Bernstein, Pasetti, M. F., Brady, R., Buskirk, A. D., Wahid, R., Dickey, M., Cohen, M., Baughman, H., El-Khorazaty, J., Maier, N., Sztein, M. B., Baqar, S., and A Bourgeois, L., A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization., Vaccine, vol. 37, no. 4, pp. 602-611, 2019.